biotech / news / / Business Standard
India's Sun Pharmaceutical Industries will buy Organon & Co in an all-cash deal.
Sun Pharmaceutical Industries will acquire Organon & Co in an all-cash deal valued at $11.75 billion.
KEY POINTS
- Sun Pharma will pay $14.00 per Organon share in cash according to the agreement.
- The acquisition grants Sun Pharma full ownership of Organon, spun off from Merck in 2021.
- Organon specializes in women's health, biosimilars, and established medicines.
COMPANIES
Summarized by Newsio from Business Standard. How we summarize →